MedPath

Ginger and Ondansetron tablets on Nausea and Vomiting in pregnancy

Phase 2
Recruiting
Conditions
ausea and Vomiting in pregnancy.
Vomiting of pregnancy, unspecified
Registration Number
IRCT20171007036600N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
116
Inclusion Criteria

Age between 18-35 years
Gestational age 10-15 weeks
Single pregnancy
knowing the exact time of last menstrual period (LMP) or having a precised sonographic result
Ability to read and write

Exclusion Criteria

The presence of diseases such as kidney disease, high blood pressure, epilepsy, diabetes and hepatitis, digestive diseases that may lead to nausea and vomiting
Unwanted pregnancy
Severe vomiting in pregnancy
Smoking
Symptoms of abortion; miscarriage or molar pregnancy
Pregnancy following infertility
Undesirable events in the past, such as severe disagreement with a partner, death of spouse or first degree relatives
Consuming agents such as iron that exacerbate nausea and vomiting during the last week
Consuming anti-inflammatory drugs for at least 3 days
Sensitivity to ginger

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of Nausea. Timepoint: Before intervention and three days after that. Method of measurement: Rodes standard questionnaire.;Rate of Nausea. Timepoint: Before intervention and three days after that. Method of measurement: Rodes standard questionnaire.;Duration of Nausea. Timepoint: Before intervention and three days after that. Method of measurement: Rodes standard questionnaire.;Severe Vomiting. Timepoint: Before intervention and three days after that. Method of measurement: Rodes standard questionnaire.;Rate of Vomiting. Timepoint: Before intervention and three days after that. Method of measurement: Rodes standard questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath